Effect of Structural Modulation of Polyphenolic Compounds on the Inhibition of Escherichia Coli ATP Synthase

Overview

Journal Int J Biol Macromol

Publisher Elsevier

Date 2012 Jan 31

PMID 22285988

Citations 18

Authors

Zulfiqar Ahmad

Mubeen Ahmad

Florence Okafor

Jeanette Jones

Abdelmajeed Abunameh

Rakesh P Cheniya

Ismail O Kady

Affiliations

Soon will be listed here.

Abstract

In this paper we present the inhibitory effect of a variety of structurally modulated/modified polyphenolic compounds on purified F(1) or membrane bound F(1)F(o)Escherichia coli ATP synthase. Structural modulation of polyphenols with two phenolic rings inhibited ATP synthase essentially completely; one or three ringed polyphenols individually or fused together inhibited partially. We found that the position of hydroxyl and nitro groups plays critical role in the degree of binding and inhibition of ATPase activity. The extended positioning of hydroxyl groups on imino diphenolic compounds diminished the inhibition and abridged position enhanced the inhibition potency. This was contrary to the effect by simple single ringed phenolic compounds where extended positioning of hydroxyl group was found to be effective for inhibition. Also, introduction of nitro group augmented the inhibition on molar scale in comparison to the inhibition by resveratrol but addition of phosphate group did not. Similarly, aromatic diol or triol with rigid or planar ring structure and no free rotation poorly inhibited the ATPase activity. The inhibition was identical in both F(1)F(o) membrane preparations as well as in isolated purified F(1) and was reversible in all cases. Growth assays suggested that modulated compounds used in this study inhibited F(1)-ATPase as well as ATP synthesis nearly equally.

Citing Articles

Insights into the potential dual-antibacterial mechanism of Kelisha capsule on Escherichia coli.

Shi G, Lu X, Zheng Y, Yang T, Zhu E, Song Y BMC Complement Med Ther. 2024; 24(1):207.

PMID: 38807130 PMC: 11134901. DOI: 10.1186/s12906-024-04500-7.

Inhibitors of ATP Synthase as New Antibacterial Candidates.

Mackieh R, Al-Bakkar N, Kfoury M, Roufayel R, Sabatier J, Fajloun Z Antibiotics (Basel). 2023; 12(4).

PMID: 37107012 PMC: 10135114. DOI: 10.3390/antibiotics12040650.

Evaluation of double expression system for co-expression and co-immobilization of flavonoid glucosylation cascade.

Matera A, Dulak K, Sordon S, Wasniewski K, Huszcza E, Poplonski J Appl Microbiol Biotechnol. 2022; 106(23):7763-7778.

PMID: 36334126 PMC: 9668961. DOI: 10.1007/s00253-022-12259-5.

Beneficial effect of polyphenols in COVID-19 and the ectopic F F -ATP synthase: Is there a link?.

Panfoli I, Esposito A J Cell Biochem. 2022; 123(8):1281-1284.

PMID: 35838055 PMC: 9349505. DOI: 10.1002/jcb.30306.

Inhibition of peptidyl arginine deiminase, a virulence factor, by antioxidant-rich : and evaluation.

Tan S, Yam H, Cheong S, Chow Y, Bok C, Ho J Saudi J Biol Sci. 2022; 29(4):2573-2581.

PMID: 35531186 PMC: 9073004. DOI: 10.1016/j.sjbs.2021.12.037.

References

Perlin D, Latchney L, Senior A . Inhibition of Escherichia coli H+-ATPase by venturicidin, oligomycin and ossamycin. Biochim Biophys Acta. 1985; 807(3):238-44. DOI: 10.1016/0005-2728(85)90254-3. View

Ahmad Z, Senior A . Role of betaAsn-243 in the phosphate-binding subdomain of catalytic sites of Escherichia coli F(1)-ATPase. J Biol Chem. 2004; 279(44):46057-64. DOI: 10.1074/jbc.M407608200. View

Gledhill J, Montgomery M, Leslie A, Walker J . Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc Natl Acad Sci U S A. 2007; 104(34):13632-7. PMC: 1948022. DOI: 10.1073/pnas.0706290104. View

Johnson K, Cleary J, Fierke C, Opipari Jr A, Glick G . Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase. ACS Chem Biol. 2006; 1(5):304-8. DOI: 10.1021/cb600143j. View

Wallace D . A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005; 39:359-407. PMC: 2821041. DOI: 10.1146/annurev.genet.39.110304.095751. View

Andries K, Verhasselt P, Guillemont J, Gohlmann H, Neefs J, Winkler H . A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science. 2004; 307(5707):223-7. DOI: 10.1126/science.1106753. View

Dadi P, Ahmad M, Ahmad Z . Inhibition of ATPase activity of Escherichia coli ATP synthase by polyphenols. Int J Biol Macromol. 2009; 45(1):72-9. DOI: 10.1016/j.ijbiomac.2009.04.004. View

Chinnam N, Dadi P, Sabri S, Ahmad M, Kabir M, Ahmad Z . Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner. Int J Biol Macromol. 2010; 46(5):478-86. PMC: 2862773. DOI: 10.1016/j.ijbiomac.2010.03.009. View

Schagger H, Ohm T . Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis. Eur J Biochem. 1995; 227(3):916-21. DOI: 10.1111/j.1432-1033.1995.tb20219.x. View

10.

Nishino H, Murakoshi M, Mou X, Wada S, Masuda M, Ohsaka Y . Cancer prevention by phytochemicals. Oncology. 2005; 69 Suppl 1:38-40. DOI: 10.1159/000086631. View

11.

Frasch W . The participation of metals in the mechanism of the F(1)-ATPase. Biochim Biophys Acta. 2000; 1458(2-3):310-25. DOI: 10.1016/s0005-2728(00)00083-9. View

12.

Ahmad Z, Senior A . Mutagenesis of residue betaArg-246 in the phosphate-binding subdomain of catalytic sites of Escherichia coli F1-ATPase. J Biol Chem. 2004; 279(30):31505-13. DOI: 10.1074/jbc.M404621200. View

13.

Stahl W, Sies H . Carotenoids and flavonoids contribute to nutritional protection against skin damage from sunlight. Mol Biotechnol. 2007; 37(1):26-30. DOI: 10.1007/s12033-007-0051-z. View

14.

TAUSSKY H, SHORR E . A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem. 1953; 202(2):675-85. View

15.

Ahmad Z, Senior A . Involvement of ATP synthase residues alphaArg-376, betaArg-182, and betaLys-155 in Pi binding. FEBS Lett. 2005; 579(2):523-8. DOI: 10.1016/j.febslet.2004.12.022. View

16.

Barta I, Smerak P, Polivkova Z, Sestakova H, Langova M, Turek B . Current trends and perspectives in nutrition and cancer prevention. Neoplasma. 2006; 53(1):19-25. View

17.

Noji H, Yoshida M . The rotary machine in the cell, ATP synthase. J Biol Chem. 2000; 276(3):1665-8. DOI: 10.1074/jbc.R000021200. View

18.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

19.

Senior A, Latchney L, Ferguson A, Wise J . Purification of F1-ATPase with impaired catalytic activity from partial revertants of Escherichia coli uncA mutant strains. Arch Biochem Biophys. 1984; 228(1):49-53. DOI: 10.1016/0003-9861(84)90045-6. View

20.

Zheng J, Ramirez V . Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol. 2000; 130(5):1115-23. PMC: 1572158. DOI: 10.1038/sj.bjp.0703397. View